U.S. Markets close in 6 hrs 24 mins

How Is Biogen’s Tecfidera Positioned in 2019?

Margaret Patrick
How Is Biogen’s Tecfidera Positioned in 2019?

Gilead Sciences or Biogen: Which Is the Better Biotech Pick?(Continued from Prior Part)MS revenue performance in the first quarterIn the first quarter, Biogen (BIIB) reported MS (multiple sclerosis) franchise revenue of ~$2.1 billion including